Gene and cell therapies have a very high upfront cost, which will no doubt grab some headlines, but the government's financial outlay may not be significantly different from what it already pays for high-cost medicines treating chronic conditions over a lifetime.
Latest Video
New Stories
-
Government backs new national push to close bone health testing gap for women
October 27, 2025 - - Latest News -
Leadership change at PolyNovo as long-time Chair steps down
October 27, 2025 - - Australian Biotech -
Cann Group announces major debt restructure and capital raise to strengthen balance sheet
October 27, 2025 - - Australian Biotech -
FDA awards the first-ever national priority vouchers to nine sponsors
October 27, 2025 - - Latest News -
Cancer Australia looks to accelerate the delivery of national plan
October 27, 2025 - - Latest News -
Mark Butler announces the additon of another contraception option to the PBS
October 27, 2025 - - Latest News -
Medicines Australia hardens stance as US pressure sharpens spotlight on PBS pricing
October 26, 2025 - - Latest News
